Popliteal Vein Aneurysm: A Rare Cause of Pulmonary Emboli

Ann Vasc Surg. 2017 Jan:38:315.e15-315.e17. doi: 10.1016/j.avsg.2016.05.093. Epub 2016 Aug 12.

Abstract

Venous aneurysms are a rare pathology that was first reported in the literature in 1968. Popliteal venous aneurysms (PVAs) are the most common lower limb venous aneurysm and have significant consequences including deep vein thrombosis, pulmonary embolus (PE), and death. A 52-year-old woman presented with chest pain and shortness of breath. A computed tomography (CT) angiography demonstrated bilateral pulmonary emboli, and she was commenced on rivaroxaban. History revealed no significant risk factors, and a thrombophilia screen was negative. However, an aneurysmal popliteal vein as seen on an ultrasound scan that was further clarified with CT venography. She underwent an uncomplicated open tangential resection and lateral venorrhaphy. The diagnosis of PVA is usually made incidentally during investigations for pulmonary embolism or chronic venous insufficiency. Surgery is indicated in all symptomatic patients with PE as anticoagulation alone is inadequate in these patients. Surgery is also recommended in patients with asymptomatic saccular aneurysms or large (>20 mm) fusiform aneurysms. The current mainstay of treatment for PVAs is open surgical management.

Publication types

  • Case Reports

MeSH terms

  • Aneurysm / complications*
  • Aneurysm / diagnostic imaging
  • Aneurysm / therapy
  • Anticoagulants / therapeutic use
  • Computed Tomography Angiography
  • Female
  • Humans
  • Middle Aged
  • Phlebography / methods
  • Popliteal Vein* / diagnostic imaging
  • Popliteal Vein* / surgery
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / etiology*
  • Pulmonary Embolism / therapy
  • Risk Factors
  • Rivaroxaban / therapeutic use
  • Treatment Outcome
  • Vascular Surgical Procedures

Substances

  • Anticoagulants
  • Rivaroxaban